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Abstract
Background: Fibroblast growth factors (FGFs) are growth factors that have diverse
biological activities including broad mitogenic and cell survival activities. They function
through the activation of a specific tyrosine kinase receptor that transduces the signal
by activating several intracellular signaling pathways.
Objective: To identify the different signaling pathways involved in the mechanism of
action of FGF8 and FGF18 on ovine granulosa cells using mass spectrometry.
Materials and Methods: Ovine ovarian granulosa cells were harvested from adult
sheep independently at the stage of the estrous cycle and were cultured at a density
of 500,000 viable cells in 1 ml DMEM/F12 medium for five days. The cells were then
treated on day 5 of culture with 10 ng/mL FGF8 and FGF18 for 30 minutes, and total
cell protein was collected for mass spectrometry.
Results: Mass spectrometry showed that both FGF8 and FGF18 significantly induce
simultaneous upregulation of several proteins, including ATF1, STAT3, MAPK1, MAPK3,
MAPK14, PLCG1, PLCG2, PKCA, PIK3CA, RAF1, GAB1, and BAG2 (> 1.5-fold; p < 0.01).
Conclusion: ATF1 and STAT3 are important transcription factors involved in cell growth,
proliferation and survival, and consequently can hamper or rescue the normal ovine
reproductive system function.
Key words: Fibroblast growth factors, Proteomics, Mass spectrometry, Granulosa cell,
Proliferation.
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1. Introduction
The fibroblast growth factors (FGFs) are growth
factors that have diverse biological activities includ-
ing broad mitogenic and cell survival activities
(1). FGFs constitute a large family of 22 distinct
polypeptide growth factors varying in size from 17
to 34 kDa (2). They play a fundamental role in
the regulation of embryogenesis. More precisely,
they are responsible for cell growth, differentia-
tion, proliferation, and cell migration. FGFs play
a fundamental role in several stages of follicular
development from preantral to preovulatory stage.
Specifically, FGFs have been identified to regulate
the initiation of primordial follicle growth, granu-
losa, and theca cell proliferation, differentiation,
angiogenesis, and steroidogenes (3). It is pre-
sumed that FGF8 and FGF18 have similar receptor
activation patterns leading to similar actions in
ovine granulosa cells (4). A recent study proposed
that FGF8 and FGF18 increase follicular health
by increasing proliferation and suppressing cell
differentiation (5).
The FGF receptors (FGFRs) include four major
receptors (FGFR1-4) that, like other receptor tyro-
sine kinase, are activated by specific ligands.
FGFRs are composed of two or three Ig-like loops
in the external domain, a transmembrane domain
and a ligand-activated cytoplasmic tyrosine kinase
domain (6, 7). The two membrane-proximal Ig
loops (Ig-II and Ig-III) comprise the ligand binding
domain, although alternative splicing of Ig-loop III
can generate isoforms (III b and III c) with distinct
ligand binding properties and tissue distributions
(8). Binding of FGF and HSPG to the extracellular
ligand domain of FGFR (FGFR1c, FGFR2c, FGFR3c,
FGFR3b, and FGFR4) induces receptor dimeriza-
tion, activation, and autophosphorylation of mul-
tiple tyrosine residues in the cytoplasmic domain
of the receptor molecule (9). A variety of signaling
proteins are phosphorylated in response to the
FGF stimulation including Shc, PLCγ, STAT1, Gab1,
and FRS2α leading to stimulation of intracellular
signaling pathways that control cell proliferation,
cell differentiation, cell migration, cell survival, and
cell shape (10). The docking proteins FRS2α and
FRS2β are major mediators of the Ras/MAPK and
PI-3 kinase/Akt signaling pathways as well as
negative feedback mechanisms that fine-tune the
signal that is initiated at the cell surface following
FGFR stimulation (11). This pathway is important in
granulosa cells (12). Signal transducer and activator
of transcription 3 (STAT3) was identified as a
phospho-dependent partner for FGFRs. STAT3 has
a key role in many cellular processes such as cell
growth and apoptosis (13).
The objective of the present study was to
compare the effects of FGF8 and FGF18 on cell
growth using the ovine granulosa cell model. Since
FGF8 and FGF18 are homologous factors that share
similar amino acid sequence but also differences,
we hypothesized that they may interact differently
to FGF receptors (i.e. FGFR2 and FGFR3) leading to
distinct effects on granulosa cell such as induction
of proliferation when they are exposed to FGF8 or
18 for a short period of time. Thus, we compared
at the proteome level the effects triggered by
FGF8 or FGF18 on the activation of FGFRs on
ovine granulosa cells. A bottom-up proteomic mass
spectrometry with label-free quantification was
used followed by bioinformatic analyses.
2. Materials and Methods
This study is a fundamental and in vitro
research study, and all the materials used were
collected from the slaughterhouses across Que-
bec province in 2015–2017. All materials for cell
culture were obtained from Life Technologies
Inc. (Thermo Fisher Scientific, Burlington, ON,
Canada) unless otherwise stated. Ovine granulosa
cells were cultured in serum-free conditions that
maintain estradiol secretion and responsiveness
to follicle-stimulating hormone (14). Ovine ovaries
were obtained from adult sheep irrespective of
the stage of estrous cycle, at an abattoir and
transported to the laboratory at 30°C in phosphate-
buffered saline containing penicillin (100 µg/mL),
streptomycin (100 µg/mL), and fungizone (1 µg/mL).
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Granulosa cells were harvested from follicles 12mm
diameter, and the cell suspension was filtered
through a 150-mesh steel sieve (sigma-Aldrich
Canada, Oakville ON). Cell viability was assessed
by trypan blue dye exclusion. Cells were seeded
into 24-well tissue culture plates (Sarstedt Inc.,
Newton, Nc) at a density of 0.5 million viable
cells in 1 mL DMEM/F12 containing sodium bicar-
bonate (10 mmol/L), sodium selenite (4 ng/mL),
bovine serum albumin (BSA) (0.1%; Sigma-Aldrich),
penicillin (100 µg/mL), streptomycin (100 µg/mL),
transferrin (2.5 µg/mL), nonessential amino acidmix
(1.1 mmol/L), bovine insulin (10 ng/mL), androstene-
dione (107 Mat the start of culture and 106 Mat each
medium change), and bovine follicle-stimulating
hormone (10 ng/mL) starting on day 2; AFP5346D;
National hormone and peptide program, Torrance,
CA). Cultures were maintained at 37°C in 5% CO2,
95% air for five days with 70% medium being
replaced on days 2 and 4. To assess the effect of
FGF8 and of FGF18 on intracellular pathway acti-
vation, cells were treated on day 5 of culture with
10 ng/mL recombinant human FGF8 and FGF18
(Pepro Tech) for 30 min, then cells were lysed and
protein solubilized in RIPA buffer. All experiments
were performed with three different pools of cells,
each collected on different occasions. The samples
were stored at –80°C pending mass spectrom-
etry analysis. Proteins were extracted from cell
samples and bottom-up proteomic analysis were
performed. The total amount of protein in each
sample was determined to use a standard Bradford
assay. Briefly, a volume corresponding to 50 µg of
proteins was used for each sample. Proteins were
isolated using a precipitation procedure with a ratio
1:3 (v:v) of acetone. The samples were centrifuged
at 9,000 g for 10min. Then, acetonewas discarded,
and protein pellet was dried for 20 min in a vacuum
centrifuge set at 60°C. The protein pellet was
dissolved in 100 µL of 50 mM ammonium bicar-
bonate (pH = 8), and the solution was sonicated
for 60 min at maximum intensity to improve and
protein dissolution yield. Reduction and alkylation
were performed as previously described (15), then,
2 µg of proteomic-grade trypsin was added, and
the reaction was performed at 40°C for 24 hr. The
protein digestion was quenched by adding 10 µL
of a 2% TFA solution. Samples were centrifuged
at 12,000 g for 10 min, and the supernatants were
transferred into injection vials for analysis.
The HPLC system was a Thermo Scientific
UltiMate 3000 Rapid Separation UHPLC system
(San Jose, CA, USA). The chromatography was
achieved using a gradient mobile phase along
with a microbore column Thermo Biobasic C8
100×1 mm, with a particle size of 5 μm. The initial
mobile phase condition consisted of acetonitrile
and water (both fortified with 0.1% of formic acid)
at a ratio of 5:95. From 0 to 1 min, the ratio was
maintained at 5:95. From 1 to 61 min, a linear
gradient was applied up to a ratio of 50:50 and
maintained for 2 min. The mobile phase compo-
sition ratio was reverted at the initial conditions,
and the column was allowed to re-equilibrate
for 14 min for a total run time of 77 min. The
flow rate was fixed at 75 µL/min, and 2 µL of
samples were injected. A Thermo Scientific Q
Exactive Orbitrap Mass Spectrometer (San Jose,
CA, USA) was interfaced with a Thermo Scientific
UltiMate 3000 Rapid Separation UHPLC system
using a pneumatic assisted heated electrospray ion
source. MS detection was performed in positive
ion mode and operating in scan mode at high-
resolution, and accurate-mass (HRAM). Nitrogen
was used for sheath and auxiliary gases, and they
were set at 10 and 5 arbitrary units. The ESI
voltage was set to 4000 V and the ion transfer
tube temperature was set to 300°C. The default
scan range was set to m/z 4001500. Data was
acquired at a resolving power of 140,000 (FWHM)
using automatic gain control targets of 3.0×106
and maximum ion injection time of 200 msec.
Additionally, MS data were acquired using a data-
dependent top-10 method to dynamically choose
the most abundant precursor ions from the survey
scans (400-1500 Da) and generate MS/MS spectra.
Instrument calibration was performed prior to all
analysis, and mass accuracy was notably below
1 ppm using Thermo Pierce calibration solution and
automated instrument protocol.
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2.1. Ethical consideration
This research study was done using ovine
ovarian samples obtained from slaughterhouses
in Québec. These experiments were approved by
the Animal Ethics Committee of the Faculty of
Veterinary Medicine of the Université de Mon-
tréal.
2.2. Statistical analysis
Database surveys were performed using Pro-
teome Discoverer software (version 2.1) with
Uniprot ovine protein database (extracted FASTA
file). Mass tolerance of precursor and fragment
(i.e., typically b and y) were set at 5 ppm and
10 ppm, respectively. Phosphorylation at Y and T
amino acids was set as a variable post-translational
modification. Quantification was based on MS1 ion
intensity, and peptide identification was based on
precursor ion (MS1) and at least three characteristic
(MS2).
Label-free MS1 quantification of peptide/pro-
tein via peak intensity was performed using
SIEVE (version 2.1), a label-free differential expres-
sion software that aligns the MS spectra over
time from different data sets and then deter-
mines the structures in the data (m/z and reten-
tion time pairs) that differ. These differences
were examined using statistical methods (e.g., p-
value and standard deviation) and then sorted
based on significance using the peak intensity
values obtained from the data of each bio-
logical replicate. The p-values with four deci-
mal significant digits are provided in Table I.
The following parameters were set to align the
retention time and generate the frames needed
for abundance calculations. Alignment Parame-
ters; Alignment Bypass = False, Correlation Bin
Width = 1, RT Limits for Alignment = True, Tile
size = 300, Max RT Shift = 0.2, m/z Min = 400, m/z
Max = 1,500, Frame time Width (min) = 2.5 min-
utes, Frame m/z width = 10 ppm, Retention Time
Start = 2.0 min, Retention Time Stop = 65 min,
Peak Intensity threshold = 100,000. Significance
was calculated within SIEVE using a standard t-test,
and results were filtered using the identification
criteria stated earlier. Statistical significance was
set at a p-value < 0.01. Interactomic analyzes were
performed using Genemania and STRING inter-
faces and databases.
3. Results
Mass spectrometry showed that both FGF8 and
FGF18 significantly induce simultaneous upregu-
lation of several proteins, and Table I includes
the most abundant proteins observed and val-
idated based on spectral libraries and in silico
bottom-up proteomic analyses (e.g., Proteome
Discoverer-SEQUEST). A total of 32 up-regulated
proteins (i.e., fold change > 1.5 for FGF8 or
FGF18) were identified, as shown in Table I.
Figure 1 exhibits a volcano plot revealing dif-
ferentially expressed proteins between control
and FGF8 (Figure 1A) as well as control versus
FGF18 (Figure 1B). As displayed, the exposition
of ovine granulosa cells to FGF8 or FGF18 has
led to a significant up-regulation of numerous
proteins, and very few were down-regulated. More-
over, very few proteins were unaffected by either
FGF8 or FGF18. This observation is coherent
with an early onset of cell growth and prolif-
eration, an expected outcome since FGFR sig-
naling pathways are associated with both. Addi-
tionally, despite it not being statistically signifi-
cant, we observed a more important up-regulation
following the exposition to FGF18 compared to
FGF8.
In Table I, the significance was calculated within
SIEVE using a standard t-test and results were
filtered using the identification criteria stated
earlier. These differences were examined using
statistical methods (e.g., p-value and standard
deviation) and then sorted based on significance
using the peak intensity values obtained from the
data of each biological replicate (control, FGF8,
and FGF18). Statistical significance was set at a
p < 0.01.
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Table I. Proteins whose level of phosphorylation was increased in response to FGF8 and FGF18 in ovine ovarian granulosa cells
Protein Accession No FGF8 FGF18
Fold change (SD) P-value Fold change (SD) P-value
CAMK2A Q9UQM7 1.41 (0.056) 0.0001 1.56 (0.067) 0.0002
YWHAB P31946 1.23 (0.042) 0.0170 1.58 (0.065) 0.0001
GRB10 Q13322 1.29 (0.030) 0.0040 1.59 (0.040) 0.0001
TRADD Q15628 1.25 (0.035) 0.0117 1.60 (0.040) 0.0018
EPHA5 P54756 1.40 (0.086) 0.0217 1.62 (0.086) 0.0040
PLCG2 P16885 1.35 (0.042) 0.0002 1.64 (0.051) 0.0070
IRF2BP1 Q8IU81 1.48 (0.042) 0.0174 1.64 (0.062) 0.024
PIK3CA P42336 1.40 (0.030) 0.0126 1.65 (0.044) 0.0024
YWHAE P6225 1.58 (0.025) 0.0017 1.67 (0.046) 0.009
STAT3 P40763 1.54 (0.058) 0.0001 1.67 (0.065) 0.001
IGF1 Q00997 1.46 (0.04) 0.0003 1.69 (0.054) 0.0002
MDM2 Q00987 1.47 (0.075) 0.0034 1.71 (0.076) 0.022
PLCG1 P19147 1.68 (0.182) 0.0222 1.71 (0.206) 0.0151
ATK1 O00139 1.57 (0.080) 0.0007 1.71 (0.098) 0.0073
KRAS P01116 1.44 (0.098) 0.042 1.71 (0.160) 0.006
MAPK14 Q16539 1.28 (0.055) 0.0001 1.72 (0.081) 0.0007
MAPK3 P27361 1.79 (0.141) 0.014 1.76 (0.074) 0.0003
MAP2K1 Q02750 1.29 (0.291) 0.8360 1.77 (0.348) 0.12
HRAS P01112 1.35 (0.162) 0.0416 1.78 (0.229) 0.0515
MAPK1 P28482 1.88 (0.037) 0.0001 2.01 (0.043) 0.0003
PGRMC1 O00264 1.85 (0.062) 0.062 2.02 (0.118) 0.005
CTSA P10619 1.68 (0.081) 0.0001 2.04 (0.121) 0.0007
GPS2 Q13227 1.45 (0.138) 0.0070 2.08 (0.203) 0.003
XDH P47989 1.68 (0.086) 0.0003 2.12 (0.102) 0.0001
RASGRP3 Q81V61 1.58 (0.177) 0.006 2.32 (0.275) 0.0010
GAB1 Q13480 1.79 (0.263) 0.0052 2.67 (0.371) 0.0009
RAF1 P04049 2.07 (0.510) 0.0042 2.75 (0.645) 0.0042
BAG2 O95816 2.03 (0.881) 0.0106 3.07 (1.069) 0.351
SNX3 O60493 1.78 (0.408) 0.0065 3.09 (0.434) 0.002
SF3A3 Q12874 3.47 (1.316) 0.030 4.39 (1.648) 0.003
PKCA P17252 3.52 (1.581) 0.022 4.44 (1.764) 0.095
ATF1 P18846 6.11 (2.983) 0.010 8.90 (3.793) 0.028
CAMK2A: Calcium/calmodulin-dependent protein kinase type II alpha chain (CAMKIIα); YWHAB: 14-3-3 protein beta/alpha;
GRB10: Growth factor receptor-bound protein 10; TRADD: Tumor necrosis factor receptor type 1-associated DEATH
domain protein; EPHA5: EPH receptor A5 (ephrin type-A receptor 5); PLCG2: 1-Phosphatidylinositol-4, 5-bisphosphate
phosphodiesterase gamma-2; IRF2BP1: Interferon regulatory factor 2 binding protein 1; PIK3CA: phosphatidylinositol-4, 5-
bisphosphate 3-kinase, catalytic subunit alpha; YWHAE: 14-3-3 protein epsilon; STAT3: Signal transducer and activator
of transcription 3; IGF1: Insulin-like growth factor 1; MDM2: Mouse double minute 2 homolog; PLCG1: Phospholipase C,
gamma 1; ATK1: kinesin like protein in Arabidopsis thaliana; KRAS: Kirsten rat sarcoma ; MAPK14: Mitogen-activated protein
kinase 14; MAPK3: Mitogen-activated protein kinase 3; HRAS: GTPase HRas also known as transforming protein p21;
PGRMC1: Progesterone receptor membrane component 1; CTSA: Cathepsin A; GPS2: G protein pathway suppressor 2; XDH:
Xanthine dehydrogenase; RASGRP3: Ras guanyl-releasing protein 3; GAB1: GRB2-associated-binding protein 1; RAF1: Rapidly
accelerated fibrosarcoma; BAG2: BAG family molecular chaperone regulator 2; SNX3: Sorting nexin-3; SF3A3: Splicing factor
3A subunit 3; PKCA: Protein kinase c; ATF1: Cyclic AMP-dependent transcription factor.
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Figure 1. A volcano plot revealing differentially expressed proteins between control and FGF8 (A) as well as control versus FGF18
(B). As displayed, the exposition of ovine granulosa cells to FGF8 or FGF18 has led to a significant up-regulation of numerous
proteins and very few were down-regulated. Also, significance was calculated within SIEVE using a standard t-test. Statistical
significance was set at a p-value < 0.01.
4. Discussion
This observation is compatible with our initial
hypothesis. FGF8 and FGF18 are homologous
growth factors that possess similar sequence
homology, but they appear to interact with FGFRs
differently leading to a more pronounce growth
or proliferation effect that may lead to a distinct
outcome for granulosa cells.
Interestingly, two very important transcription
factors were identified, STAT3 and ATF1. STAT3
is a member of the STAT family that was iden-
tified as a DNA-binding factor (4, 16) and is
expressed early during post-implantation in most
tissues. Moreover, STAT3−/− mice are character-
ized by embryonic lethality. STAT3 is involved
in promoting cell growth and is constitutively
active and potentiate tumorigenesis (17, 18). Pro-
oncogenic STAT3 activity is linked with gene
expression that is known to promote proliferation
and inhibit apoptosis (19). Several serine kinases
have been reported to be involved in the serine
phosphorylation of STATs, including MAPK14 and
MAPK1/3 that were also up-regulated following the
exposition of granulosa cell to FGF8 and FGF18
for 30 minutes. With the advances in proteomic
science, STAT3 was identified as an important
molecule that plays numerous roles in cells. It has
a two-fold role as a mediator of signaling and
regulator of gene expression. Furthermore, STAT3
has been widely described as an oncogene cor-
related with tumor progression and up-regulated
in many tumor specimens (20). Consequently,
STAT3 signaling pathway could be considered as
a promising therapeutic target. As shown in Table
I and Figure 2, many members of the MAPK/ERK
pathway were significantly up-regulated following
the exposition of granulosa cells to FGF8 and
FGF18 for 30 min. Growth factors and mitogens
use the MAPK/ERK pathway signaling cascade
to signal the regulation of gene expression and
prevent apoptosis. Some constituents of these
pathways are mutated or abnormally expressed
in cancer. However, it may be advantageous to
induce MAPK/ERK pathway expression to promote
cell cycle arrest to stop deregulated cell prolif-
eration. Activation of transcription factor 1 (ATF1)
was significantly up-regulated following the expo-
sition of granulosa cells to FGF8 and FGF18 for
30 minutes. ATF1 and RAS proteins were found
significantly elevated in various tumors and were
recently identified as potential clinical diagnostic
biomarkers (21). Also, an important aspect is that
ATF1 is up-regulated upon stress as part of a
cell adaptation mechanism (22). ATF1 and CREB
interact and are important for cell survival, par-
ticularly during early development. The extensive
up-regulation of ATF1 could be a consequence
of the onset of STAT3 promoting cell growth
(23).
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Analysis of the STAT3 and ATF1 interactome
(Genemania interface and database) shown in
Figure 3 outline the important genetic interactions
and co-expression (Figures 3A and 3C) for all
the abundant proteins observed and presented in
Table I and Figure 2. There is a strong genetic
association between STAT3 and ATF1 but a minor
physical or pathway association. This observation
is also validated with a STRING analysis (i.e.,
predicted protein–protein interactions) in Figure
3D. This is coherent with our hypothesis that
ATF1 might counterbalance the STAT3-induced cell
growth, proliferation, and potentiation of tumori-
genesis using an independent pathway. The
interactomic analyses performed with Genemania
and STRING presented in Figure 3 confirm a
high degree of genetic and physical interactions
between MAPK/ERK pathway signaling cascade
with STAT3 and ATF1, which is coherent with
symmetrical up-regulation observed following the
exposition of granulosa cell to FGF8 and FGF18 for
30 min.
Figure 2. It is a graphical representation of Table I.
Figure 3. The interactomic analysis were performed using STRING interfaces and databases (this is not a statistical study).
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5. Conclusion
In summary, in ovine granulosa cells, FGF8
and FGF18 induced a significant up-regulation of
numerous proteins associated with the MAPK/ERK
pathway. More importantly, two important tran-
scription factors were significantly up-regulated,
STAT3 and ATF1, both interacting strongly with the
MAPK/ERK pathway. The findings from this study
described for the first time the FGF8 and FGF18
up-regulation of ATF1 and STAT3 expression in
granulosa cells. Interestingly, STAT3 and ATF1 are
involved in promoting cell growth and proliferation,
and constitutively active STAT3 is able to potentiate
tumorigenesis.
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